Respiratory Burst Assay Kit (Neutrophil/Monocyte)
4
(1 Review)
|
(4 Publications)
- FuncS
Supplier Data
Functional Studies - Respiratory Burst Assay Kit (Neutrophil/Monocyte) (AB236210)
Flow cytometric analysis of human peripheral blood.
Human peripheral blood was treated with Dihydrorhodamine 123 Assay Reagent followed by stimulation with PMA for 45 minutes to induce the respiratory burst. The RBC were lysed and the leukocytesanalysed by flow cytometry. Left panel : Forwardangle light scatter(FSC) and side scatter (SSC) segregate neutrpgils (gate P1), monocytes (gate P2) and lymphocytes (gate P3) for susequent analysis in the other panels.
Remaining panels : Enhanced oxidation of Dihydrorhodamine 123 Assay Reagent to rhodamine 123 is indicated by a right shift in the x-axis FL1 fluorescence in the gated neutrophils and monocytes, but not in the lymphocytes. The black lines represent untreated cells and the red lines represent PMA-treated cells.
- FuncS
Supplier Data
Functional Studies - Respiratory Burst Assay Kit (Neutrophil/Monocyte) (AB236210)
Flow cytometric analysis of mouse neutrophil respiratory burst.
Mouse bone marrow cells (top) and caesi-induced peritoneal exudate cells (bottom) were treated with Dihydrorhodamine 123 Assay Reagent followed by stimulation with PMA (100 nM) for 45 minutes to induce the respiratory burst. The RBC were lysed and the leukocytes analyzed by flow cytometry. Left panels : The neutrophils are identified by an intermediate forward angle light scatter (FSC) and high side scatter (SSC), and are gated (P1) for subsequent analysis in the other panels. Right panels : Enhanced oxidation of Dihydrorhodamine 123 Assay Reagent to rhodamine 123 is indicated by a right shift in the x-axis FL1 fluorescence in the gated neutrophils from samples treated with PMA (red line) versus untreated cells (black line).
- FuncS
Supplier Data
Functional Studies - Respiratory Burst Assay Kit (Neutrophil/Monocyte) (AB236210)
PMA dose-response.
Human peripheral blood was treated with Dihydrorhodamine 123 Assay Reagent followed by stimulation with the indicated concentrations of PMA for 45 minutes to induce the respiratory burst. The RBC were lysed and the leukocytes analyzed by flow cytometry.
Product details
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The respiratory burst facilitates the destruction of microbial invaders inside phagocytic cells. This process is independent yet complementary to the lysosomal degradation in these cells. ROS generated during the oxidative burst participate in direct microbial killing and enhancing signaling pathways that further stimulate immune responses. The NADPH oxidase complex catalyzes the reduction of oxygen to superoxide which functions as a precursor for other ROS. This enzymatic machinery is important for efficient pathogen eradication and is integral to the innate immune response.
Pathways
The respiratory burst intertwines with the pathways related to immune responses and inflammation. One critical pathway is the MAPK signaling pathway which activates the burst in response to pathogen recognition. Proteins such as protein kinase C (PKC) assist in regulating the activation of NADPH oxidase during this process. Additionally the respiratory burst contributes to signaling cascades that lead to cytokine production further linking it to the inflammatory response network.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:4945 PubMed40436823
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular and infection microbiology 14:1394070 PubMed38895731
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nanomedicine : nanotechnology, biology, and medicine 54:102712 PubMed37838100
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:586685 PubMed33042165
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com